Correspondent

Dr Vivian says Singapore a “natural partner” to India despite investment fiasco at Amaravati

At the India-Singapore Business and Innovation Summit held in Mariner Bay Sands on Monday (9 Sep), Singapore’s Foreign Affairs Minister Vivian Balakrishnan said Singapore can help India in areas such as infrastructure planning, water conservation and business expansion. Dr Vivian said India aims to invest about US$13.9 billion in urban infrastructure and solutions over the next five years, as it …

Read More »

HK protests hit Watson’s business derailing Temasek’s US$3b Watson sale to potential buyers

Bloomberg reported yesterday (3 Sep) that potential investors have backed off buying over Temasek Holdings’ US$3 billion stake in retailer A.S. Watson Group. Temasek, which owns a 25% stake of Watson Group, was considering selling about 10% of the retailer to potential investors. Bloomberg reported that Temasek was in talks with Abu Dhabi’s sovereign wealth fund, Chinese internet giants Tencent …

Read More »

Indian Minister: Temasek-linked GLCs agree to “amicably back out” of Amaravati project

It was reported in Parliament yesterday (3 Sep) that Minister-in-Charge of trade relations S Iswaran said no state expenditure was involved in the Indian capital city Amaravati development. Under the previous Indian state government of Andhra Pradesh, it was decided that Amaravati would be the location of the new Indian state capital. Temasek-linked entities Ascendas-Singbridge, now under CapitalLand, and Sembcorp …

Read More »

Netizens question compulsory CareShield; One year of free scholarships to foreign students equivalent to 16 years’ ElderShield payouts

Yesterday (2 Sep), the CareShield Life Bill was passed in the PAP-dominated Parliament after its second reading, forcing Singaporeans who were born in 1980 or after to pay compulsory insurance fees starting next year. So, come next year, those aged 30 to 40 must join CareShield Life and start paying premiums. Future cohorts will join at the age of 30. …

Read More »